The hair loss market is a self-pay sector
with a 4.8% projected growth rate expected between 2012 – 2017
Currently valued at over $7 billion.
Market
Billion
treatments
Billion
Loss treatments
Billion
TOTAL.
MEN
WOMEN
SEGMENT FOCUS
ALOPECIA
- Female
- Men with early hair loss
Market Opportunity
IN RESPONDERS
DENSITY ACROSS ALL PATIENTS
IN RESPONDERS
$2.3 B (Annual sales)
$2.7 B (Annual sales)
*Source: IBISWORLD Industry Report OD4136: Hair Loss Treatment Manufacturing in the US **Source: 2015 ISHRS: Hair Follicle Stimulation by Stromal Vascular Fraction Enhanced Adipose Transplantation in Baldness, David Perez-Meza, MD, FISHRS 1 Source: A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. Olsen EA, Dunlap FE, Funicella T, Koperski JA, Swinehart JM, Tschen EH, Trancik RJ. J Am Acad Dermatol. 2002 Sep;47(3):377-85. 2 Source: Blume-Peytavi U, et al. J Am Acad Dermatol. (2011) 3 Source: Changes in hair weight in men with androgenetic alopecia after treatment with finasteride (1 mg daily): three- and 4-year results. Price VH, Menefee E, Sanchez M, Kaufman KD. J Am Acad Dermatol. 2006 Jul;55(1):71-4. 4 Source: Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group. Kaufman KD, Olsen EA, Whiting D, Savin R, DeVillez R, Bergfeld W, Price VH, Van Neste D, Roberts JL, Hordinsky M, Shapiro J, Binkowitz B, Gormley GJ. J Am Acad Dermatol. 1998 Oct;39(4 Pt 1):578-89
Kerastem Female focus
limited option for females
FEMALE PATTERN HAIR LOSS
TREATING GRADES I-II